Kari Lislerud

762 total citations
9 papers, 610 citations indexed

About

Kari Lislerud is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Kari Lislerud has authored 9 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Kari Lislerud's work include Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kari Lislerud is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kari Lislerud collaborates with scholars based in Norway, United Kingdom and Denmark. Kari Lislerud's co-authors include Gustav Gaudernack, Jon Amund Kyte, Gunnar Kvalheim, Sissel Trachsel, Steinar Aamdal, Svein Dueland, Jon Amund Eriksen, Jens Bjørheim, I. K. Bukholm and Jahn M. Nesland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kari Lislerud

9 papers receiving 596 citations

Peers

Kari Lislerud

IMMUN

ONCOL

MB

PFM

GENET

Chiara Casati Italy

Cinzia Remondo Italy

Judith A. Kantor United States

Samuel Alsén Sweden

Leticia Barba Switzerland

Yok‐Lam Kwong China

Ashley Knights Australia

Cristina Mastini Italy

Korina G. Veenstra United States

Elien M. Doorduijn Netherlands

Chiara Casati Italy

Kari Lislerud

579 ×1.5

IMMUN

563 ×1.6

ONCOL

274 ×1.2

MB

40 ×0.4

PFM

147 ×1.7

GENET

Citations per year, relative to Kari Lislerud Kari Lislerud (= 1×) peers Chiara Casati

Countries citing papers authored by Kari Lislerud

Since Specialization

Citations

This map shows the geographic impact of Kari Lislerud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Lislerud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Lislerud more than expected).

Fields of papers citing papers by Kari Lislerud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Lislerud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Lislerud. The network helps show where Kari Lislerud may publish in the future.

Co-authorship network of co-authors of Kari Lislerud

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Lislerud. A scholar is included among the top collaborators of Kari Lislerud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Lislerud. Kari Lislerud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wälchli, Sébastien, Marit Renée Myhre, Nadia Mensali, et al.. (2017). Abstract 3773: Tapping CD4 T cells for cancer immunotherapy. Cancer Research. 77(13_Supplement). 3773–3773. 1 indexed citations

2.

Kyte, Jon Amund, Gustav Gaudernack, Kari Lislerud, et al.. (2016). T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy. OncoImmunology. 5(12). e1249090–e1249090. 18 indexed citations

3.

Inderberg-Suso, Else-Marit, et al.. (2012). Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001. OncoImmunology. 1(5). 670–686. 87 indexed citations

4.

Hoel, Hanna Julie, et al.. (2010). Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy. Journal of Immunological Methods. 355(1-2). 52–60. 36 indexed citations

5.

Kyte, Jon Amund, et al.. (2009). Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination. Cancer Immunology Immunotherapy. 58(10). 1609–1626. 44 indexed citations

6.

Buanes, Trond, Stephan Bernhardt, Kari Lislerud, et al.. (2007). RAS peptide vaccination in resected pancreatic cancer patients - persistence of anti tumour response and long term survival. Journal of Clinical Oncology. 25(18_suppl). 4543–4543. 3 indexed citations

7.

Kyte, Jon Amund, Lijun Mu, Steinar Aamdal, et al.. (2006). Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Therapy. 13(10). 905–918. 162 indexed citations

8.

Kyte, Jon Amund, Gunnar Kvalheim, Kari Lislerud, et al.. (2006). T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells. Cancer Immunology Immunotherapy. 56(5). 659–675. 50 indexed citations

9.

Sæterdal, Ingvil, Jens Bjørheim, Kari Lislerud, et al.. (2001). Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proceedings of the National Academy of Sciences. 98(23). 13255–13260. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact